Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Pfizer PFE announced that the FDA approved the expansion of its PARP inhibitor Talzenna (talazoparib) in prostate cancer indication. The regulatory agency approved the combination of Talzenna with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback